Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05253651
Title A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Seagen Inc.
Indications

colorectal adenocarcinoma

Therapies

Cetuximab + Fluorouracil + Leucovorin + Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin + Trastuzumab + Tucatinib

Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST